Policy Position Paper: Rationale for Screening Individuals for Aluminum Sensitivity Prior to Aluminum-Containing Vaccination
There is more than sufficient evidence to know that some people will suffer needlessly without screening for aluminum sensitivity prior to injecting vaccines with aluminum adjuvants.
Exclusive to Popular Rationalism
Aluminum salts are widely used as adjuvants in pediatric and adult vaccines. While generally considered safe, a significant and growing body of scientific literature supports the hypothesis that a subset of individuals—particularly children—experience adverse reactions to aluminum due to hypersensitivity or allergy. Screening for aluminum sensitivity prior to vaccination could help prevent adverse events such as granulomas, persistent itching, subcutaneous nodules, or systemic atopic responses. This report summarizes the evidence supporting this precautionary approach.
Prevalence and Detection of Aluminum Sensitivity
Multiple studies have demonstrated that aluminum contact allergy is not rare, especially in children.
Siemund et al., 2022 reported a 5.1% rate of aluminum allergy in children patch-tested with aluminum chloride hexahydrate—five times the rate observed in adults. This study recommends aluminum testing be included in baseline patch series for children.
Siemund et al., 2022Bruze et al., 2022 emphasized the need for accurate testing with 10% aluminum chloride hexahydrate to identify true cases and avoid false negatives.
Bruze et al., 2022Kullberg et al., 2020 provided a literature review confirming aluminum’s role as a contact allergen and describing its cutaneous manifestations, reinforcing the value of patch testing.
Kullberg et al., 2020
Clinical Manifestations and Adverse Outcomes
Aluminum-sensitive individuals may develop pronounced local and systemic symptoms following vaccination.
Hoffmann et al., 2020 studied 177 children with vaccination granulomas and confirmed aluminum allergy. Symptoms included persistent itching and nodules, leading to decreased vaccine compliance and lower quality of life.
Hoffmann et al., 2020Mistry & DeKoven, 2021 described a systemic cutaneous eruption post-Quadracel vaccination, with patch-test-confirmed aluminum allergy that persisted for years.
Mistry & DeKoven, 2021Beveridge et al., 2012 presented a case of an infant with subcutaneous nodules following routine immunization, with confirmed aluminum contact allergy.
Beveridge et al., 2012
Immunologic Risk in Susceptible Populations
Children with genetic predisposition to atopy or immune dysregulation may be especially vulnerable.
Terhune & Deth, 2018 explained that aluminum-adjuvanted vaccines induce a Th2-biased response and may impair regulatory T cell function in genetically susceptible individuals.
Terhune & Deth, 2018Terhune & Deth, 2014 further proposed that compromised regulatory T cell responses could underlie adverse reactions in aluminum-sensitive subpopulations.
Terhune & Deth, 2014Daley et al., 2023, in a massive VSD study (n=326,991), found a statistically significant association between aluminum dose from vaccines and persistent asthma—especially in children with eczema.
Daley et al., 2023
Aluminum in Allergen Immunotherapy and the Role of Alternative Adjuvants
Although aluminum hydroxide is widely used in allergen-specific immunotherapy (AIT), its limitations and potential to induce hypersensitivity are well documented. Zubeldia et al. provide a comprehensive review of first-generation adjuvants like aluminum hydroxide, noting that while they serve as depot systems and modest immunomodulators, their allergenic potential and limited capacity to promote regulatory T cell responses make them suboptimal for certain patient populations. The authors argue for a shift toward second-generation adjuvants (e.g., MPL, microcrystalline tyrosine) that better support immune tolerance mechanisms in AIT and reduce the risk of sensitization【Zubeldia et al., 2019](https://doi.org/10.18176/jiaci.0349)】.
This reinforces the broader concern that in genetically or immunologically predisposed individuals, aluminum-containing immunizations may not just fail to induce tolerance but could exacerbate allergic profiles, further justifying the need for pre-vaccine screening in both therapeutic and prophylactic settings.
Long-Term Impact and Diagnostic Delay
Failing to screen can result in misdiagnosis, unnecessary investigations, and vaccine hesitancy.
Lidholm et al., 2023 followed children with confirmed aluminum allergy for 20 years. Many lost patch-test reactivity over time, but initial sensitization led to persistent granulomas and disrupted care.
Lidholm et al., 2023Andersen et al., 2014 highlighted the under-recognition of aluminum-induced granulomas in Denmark and emphasized the importance of early detection and reporting.
Andersen et al., 2014Nielsen et al., 1992 found 32 children with persistent itching and confirmed aluminum allergy post-DTP vaccination, calling for aluminum-free alternatives in known allergic individuals.
Nielsen et al., 1992
Support from Professional Societies and Consensus
The American Contact Dermatitis Society named aluminum the 2022 Allergen of the Year, citing its relevance in vaccine reactions and immunotherapy.
Novack et al., 2022Aquino et al., 2022 outlined how delayed hypersensitivity to aluminum is not uncommon and advocated patch testing to identify causative agents.
Aquino et al., 2022
Conclusion
The literature strongly supports that a measurable subset of children and adults—particularly those with eczema, asthma, or known atopy—should be screened for aluminum sensitivity prior to administration of aluminum-containing vaccines. This can be achieved through patch testing or clinical history and can help avoid adverse outcomes, reduce vaccine hesitancy, and personalize care without compromising public health.
Cited Works
Siemund I, Dahlin J, Hindsén M, et al. Contact Allergy to Two Aluminum Salts in Consecutively Patch-Tested Dermatitis Patients. Dermatitis. 2022;33(1):31-35. doi:10.1097/DER.0000000000000787
Kullberg SA, Ward JM, Liou YL, et al. Cutaneous Reactions to Aluminum. Dermatitis. 2020;31(6):335-349. doi:10.1097/DER.0000000000000633
Bruze M, Netterlid E, Siemund I. Aluminum—Allergen of the Year 2022. Dermatitis. 2022;33(1):10-15. doi:10.1097/DER.0000000000000836
Terhune TD, Deth RC. Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation? Int J Environ Res Public Health. 2018;15(5):901. doi:10.3390/ijerph15050901
Hoffmann SS, Thyssen JP, Elberling J, Hansen KS, Johansen JD. Children with Vaccination Granulomas and Aluminum Contact Allergy: Evaluation of Predispositions, Avoidance Behavior, and Quality of Life. Contact Dermatitis. 2020;83(2):99-107. doi:10.1111/cod.13538
Mistry BD, DeKoven JG. Widespread Cutaneous Eruption After Aluminum-Containing Vaccination: A Case Report and Review of Current Literature. Pediatr Dermatol. 2021;38(4):872-874. doi:10.1111/pde.14613
Beveridge MG, Polcari IC, Burns JL, Adler A, Hendrickson B, Stein SL. Local Vaccine Site Reactions and Contact Allergy to Aluminum. Pediatr Dermatol. 2012;29(1):68-72. doi:10.1111/j.1525-1470.2011.01541.x
Terhune TD, Deth RC. A Role for Impaired Regulatory T Cell Function in Adverse Responses to Aluminum Adjuvant-Containing Vaccines in Genetically Susceptible Individuals. Vaccine. 2014;32(40):5149-5155. doi:10.1016/j.vaccine.2014.07.052
Daley MF, Reifler LM, Glanz JM, et al. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months. Acad Pediatr. 2023;23(1):37-46. doi:10.1016/j.acap.2022.08.006
Andersen RM, Zachariae C, Johansen JD. [Aluminum Allergy and Granulomas Induced by Vaccinations for Children]. Ugeskr Laeger. 2014;176(12A):V10130633. [Article in Danish]
Lidholm AG, Inerot A, Gillstedt M, Bergfors E, Trollfors B. Long-term Prognosis of Vaccine-Induced Contact Allergy to Aluminium: Third Patch-Test With Additional Test Preparations. Contact Dermatitis. 2023;89(5):359-367. doi:10.1111/cod.14386
Nielsen AO, Kaaber K, Veien NK. [Aluminum Allergy Caused by DTP Vaccine]. Ugeskr Laeger. 1992 Jun 29;154(27):1900-1901. [Article in Danish]
Aquino MR, Bingemann TA, Nanda A, Maples KM. Delayed Allergic Skin Reactions to Vaccines. Allergy Asthma Proc. 2022;43(1):20-29. doi:10.2500/aap.2022.43.210105
Brodbaker E, Pratt M. Contact Sensitivity to Aluminum. J Cutan Med Surg. 2009;13(4):226-229. doi:10.2310/7750.2008.08046
Zubeldia JM, Ferrer M, Dávila I, Justicia JL. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response. J Investig Allergol Clin Immunol. 2019;29(2):103-111. doi:10.18176/jiaci.0349
Personally I believe that nobody should be injected with aluminum. Everyone is allergic to it--even dogs
Great minds thinking alike...https://open.substack.com/pub/jessicar/p/autism-chart-explained-and-the-inflection?utm_source=share&utm_medium=android&r=71l80